News

Jyske Bank's Strategic Share Repurchase Initiative Explained

Jyske Bank's Strategic Share Repurchase Initiative Explained

Jyske Bank's Share Repurchase Programme: An Overview

Jyske Bank is launching a significant share repurchase programme that will run from 3 June 2024 to 31 January 2025. During this period, the bank intends to buy back shares valued at up to DKK 1.5 billion. This initiative highlights Jyske Bank's dedication to boosting shareholder value while adhering to the guidelines set out in the EU Commission Regulation No. 596/2014, commonly known as the Market Abuse Regulation.

Details of the Share Transactions

Throughout this share repurchase programme, Jyske Bank has been involved in various transactions aimed at acquiring shares. This level of transparency is vital for investors and stakeholders who are tracking the programme's performance and effectiveness as it unfolds.

Accumulation of Shares to Date

According to the latest update, Jyske Bank has successfully acquired 2,680,845 shares at an average price of DKK 543.23, leading to a total transaction value of around DKK 1.46 billion. This significant figure reflects the bank's proactive stance on managing its share capital.

Recent Share Acquisitions

In recent transactions spanning the dates of 9, 10, 11, and 12 September 2024, the bank has added more shares to its holdings. Specifically, on 9 September, Jyske Bank purchased 60 shares at an average price of DKK 528.38 and acquired 13,835 shares on 10 September at DKK 521.86. These ongoing acquisitions demonstrate Jyske Bank's commitment to refining its capital structure.

Current Status of the Repurchase Programme

As per the latest summary, Jyske Bank holds a total of 2,714,819 treasury shares, which is about 4.22% of its overall share capital. This notable accumulation emphasizes the bank's strategic goal to increase shareholder value and sustain an efficient capital framework.

Commitment to Compliance and Transparency

The share buyback programme is conducted in full compliance with EU regulations, ensuring market transparency and fairness. Each transaction within this programme is subject to official disclosure in line with corporate governance rules.

Impact on the Future

With the ongoing acquisition of shares, Jyske Bank is not only solidifying its market presence but also showcasing confidence in its long-term growth potential. Such actions are likely to enhance market perception regarding the bank's stability and financial health, making it an appealing choice for investors in search of both reliability and growth.

Contact Information

If you have any questions about the share repurchase programme, please reach out to Birger Krøgh Nielsen, CFO of Jyske Bank, at +45 89 89 64 44.

Frequently Asked Questions

What is the purpose of Jyske Bank's share repurchase programme?

The main aim is to boost shareholder value by repurchasing shares worth up to DKK 1.5 billion, which helps optimize the capital structure and enhances market perception.

How many shares has Jyske Bank repurchased so far?

To date, Jyske Bank has repurchased a total of 2,714,819 treasury shares, accounting for 4.22% of their share capital.

What regulations guide Jyske Bank's programme?

The programme adheres to the EU Commission Regulation No. 596/2014, often referred to as the Market Abuse Regulation.

What are the average prices paid for the repurchased shares?

The average purchase price for shares across various transactions is roughly DKK 542.96.

Who should I contact for additional details about the initiative?

Those interested in more information can contact Birger Krøgh Nielsen, CFO of Jyske Bank, using the phone number provided earlier.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 0

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

Updated Category News Views 4

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 24

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Roadrunner's Bold Move: New LTL Service and Rate Hike

Updated Category News Views 3

When you shake up the status quo in logistics, you better be ready for the ride. Roadrunner Freight is doing just that with the launch of its first-ever outbound Canada-to-U.S. LTL service. They're shaking up a market that's been bogged down with inefficiencies for far too long. This isn't just another lane to add to a map; it's a new passage for Canadian goods, paving a...

Continue Reading
Invisors Expands PayBill Suite for Staffing Efficiency

Updated Category News Views 4

Invisors Doubles Down on Workday Integration The winds of change are whispering in the Professional & Business Services sector as Invisors rolls out its enhanced PayBill Suite. This move isn't just another tick on some corporate checklist; it's a serious play to streamline the gnarly process of transitions that staffing firms face. Invisors is tying this suite tightly...

Continue Reading
FP Movement Opens Energizing Boutique in Cranston, RI

Updated Category News Views 23

FP Movement Expands with Style in Rhode Island FP Movement is shaking things up in Cranston, Rhode Island, bringing its signature activewear vibe to Garden City Center with a new shop. It’s not just about buying leggings anymore; it’s about diving into a lifestyle that screams energy and community spirit. The store, which spans 1,209 selling-square-feet, opened its...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 23

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
JJ Lin's Iconic Singapore Grand Prix Show With 20 Songs

Updated Category News Views 3

Nothing beats the thrill of a live performance under a night sky, with the adrenaline of a Formula 1 race still in the air. On October 9, 2026, Mandopop superstar JJ Lin captivated the crowd at the Padang Stage of the Singapore Grand Prix, delivering not just a concert but a spectacle of international scale. Stage Spectacle with Precision JJ Lin took control like a...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 26

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
ASPR AI Unveils Private Sales Agent Studio

Updated Category News Views 11

Pushing Sales AI Into a Secure Future Picture a world where your most sensitive sales data stays safely behind your own digital doors. ASPR AI is shaking up the game by launching its Private Sales Agent Studio, a move that catapults enterprise sales management into a new era of control and customization. Why Private Means Business Here's the meat of it: sales AI usually...

Continue Reading

Top 5 Most Recently Viewed Articles

MediaAlpha Set for Q3 2024 Financial Results Presentation

Updated Category News Views 78

MediaAlpha's Upcoming Financial Report Announcement MediaAlpha, Inc. (NYSE: MAX), based in Los Angeles, has exciting news for its investors and stakeholders. The company is gearing up to announce its financial results for the third quarter of 2024 on an upcoming Wednesday. This announcement will take place after the market closes, providing important insights into the...

Continue Reading
Understanding Recent Trends in Canadian Stocks and Markets

Updated Category News Views 329

Canadian Stock Market Overview Recently, the Canadian stock market experienced a decline, reflecting a challenging trading environment. The decline was multifaceted, with notable tumbles in sectors such as the Consumer Staples, REITs, and Healthcare, which significantly influenced overall market performance. Investors and analysts are keenly observing these fluctuations,...

Continue Reading
Discover Key Trends in Network Observability for IT Success

Updated Category News Views 137

Emerging Trends in Network Observability Join experts as they discuss how IT leaders can adapt observability tools to meet modern network challenges. Enterprise Management Associates (EMA) is hosting an insightful webinar titled "Your NetOps Tools Are Aging Faster Than Your Network: 5 Emerging Trends That Are Reshaping Network Observability." Shamus McGillicuddy, Vice...

Continue Reading
Realbotix Secures Payment in Genesis Restructuring Efforts

Updated Category News Views 74

Realbotix Achieves Major Financial Recovery Realbotix Corp. (TSX-V: XBOT | Frankfurt Stock Exchange: 76M0.F | OTC: XBOTF) is making waves in the news by recently securing a significant cash payment of US$743,500 as part of its ongoing restructuring efforts with Genesis Global Capital. This milestone is a positive step for the Company as it works through the challenges of...

Continue Reading
Immedica Pharma's Loargys: Pioneering Hope in Rare Disease

Updated Category News Views 210

Game-Changing Approval or Just Another Hype Train? Time for a gut check: Immedica Pharma just made waves with its Loargys® (pegzilarginase-nbln), snagging accelerated FDA approval for treating hyperargininemia tied to Arginase 1 Deficiency (ARG1-D). So what's the big deal? Well, basically, we're talking about a breakthrough here—it's the first therapy proven to lower...

Continue Reading